Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.45m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Virtual shareholder event

12 Apr 2021 07:00

RNS Number : 0173V
Mercia Asset Management PLC
12 April 2021
Β 

RNS

12 April 2021

Β 

Mercia Asset Management PLC

Β 

("Mercia" the "Company" or the "Group")

Β 

Virtual shareholder event

Β 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.Β£872millionΒ of assets under management, is pleased to announce a virtual shareholder event 'The Mercia Brief'.

Β 

The Mercia Brief, which will be open to all shareholders and analysts, will showcase Mercia's team, portfolio companies and provide an overview of the Group's recent performance. The presentations will be followed by a Q&A. No new material information will be disclosed.

Β 

The event will take place on 20 April 2021 at 4pm

Β 

The Mercia Brief will be presented via piworld.co.uk and shareholders and analysts can register via this following link. http://bit.ly/MERC_Virtual_Shareholder_event

Β 

Mercia's CEO, Dr Mark Payton, will provide insight on the progress that Mercia is making on its three-year strategy. Mark will be joined by Martin Glanfield, CFO, Julian Viggars, CIO and Jill Williams, Investment Director and Mercia's ESG Lead. The event will also include short presentations from the CEOs of several Mercia investee companies within both its direct investment portfolio and third-party managed funds' portfolios.

Β 

-Ends-

Β 

For further information, please contact:

Β 

Mercia Asset Management PLC

MarkΒ Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

Β 

+44 (0)330 223 1430

Β 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel, Richard Andrews

Β 

Β 

Β 

N+1 Singer (Joint Broker)

Β 

Harry Gooden, James Moat

Β 

+44 (0)20 7496 3000

Β 

Β 

FTI ConsultingΒ 

+44 (0)20 3727 1051

Tom Blackwell, Louisa Feltes, Shiv Talwar

Β 

mercia@fticonsulting.com

Β 

Β 

About Mercia Asset Management PLC:

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

Β 

The Group has a strongΒ UKΒ footprint through its regional offices, 19 university partnerships and extensive personal networks, providing it with access to high-quality deal flow. Mercia currently has c.Β£872millionΒ of assets under management and, since its IPO in December 2014, has invested c.Β£106millionΒ gross into its direct investment portfolio.

Β 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCFKLFBFZLEBBL
Date   Source Headline
27th Oct 20217:00 amRNSNotice of Interim Results
26th Oct 20217:00 amRNSMercia announces new direct investment
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.